Cargando…
Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases
Clinical hyperthermic intraperitoneal chemotherapy (HIPEC) is regarded as a potential treatment that can prolong survival of patients with peritoneal metastases after cytoreductive surgery. However, treated tumor cells are prone to becoming heat resistant to HIPEC therapy through high expression of...
Autores principales: | Wang, Qiang, Liu, Peng, Wen, Yingfei, Li, Kuan, Bi, Bo, Li, Bin-bin, Qiu, Miaojuan, Zhang, Shiqiang, Li, You, Li, Jia, Chen, Hengxing, Yin, Yuan, Zeng, Leli, Zhang, Changhua, He, Yulong, Zhao, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265871/ https://www.ncbi.nlm.nih.gov/pubmed/37316830 http://dx.doi.org/10.1186/s12943-023-01790-2 |
Ejemplares similares
-
Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer
por: Chen, Zhi-Xiong, et al.
Publicado: (2022) -
Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture
por: Chia, Daryl K. A., et al.
Publicado: (2023) -
The Impact of Multidisciplinary Team Approach on Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
por: Hung, Hao-Chien, et al.
Publicado: (2021) -
A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021) -
Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)